• Vor Bio granted inducement equity awards on Aug. 1, 2026 to five new hires under its 2023 Inducement Plan.
• Awards include stock options for 32,550 shares, priced at USD 21.15, matching the grant-date close; options run 10 years.
• RSUs cover 6,900 shares; both options and RSUs vest over four years, with 25% after 12 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608031630PRIMZONEFULLFEED9802488) on August 03, 2026, and is solely responsible for the information contained therein.